UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Mundipharma to market Biosolution's knee cartilage defect treatment
by Lee Han-soo
2020-01-07 16:11
Fenbendazole craze expands to human parasiticide
by Lee Han-soo
2020-01-07 12:33
Eliquis price cut delayed amid prolonged administrative suit
by Kim Yun-mi
2020-01-07 11:32
Chinese drugmaker Mebo establishes branch in Korea
by Lee Han-soo
2020-01-06 14:40
[New Year Special] Boryung, Hanmi in fierce battle to fill ranitidine void
by Jeong Sae-im
2020-01-03 17:56
라인
Bukwang, Sanofi Aventis Korea to co-promote hypertension med
by Lee Han-soo
2020-01-03 17:55
Daewoong launches oral typhoid fever vaccine
by Lee Han-soo
2020-01-03 17:55
[New Year Special] Rise of digital therapeutics to change healthcare scene for good
by Lee Han-soo
2020-01-03 14:57
SK Bioscience’s influenza vaccine nabs WHO certification
by Lee Han-soo
2020-01-03 14:14
Daewoong to kick off P3 trial of Nabota in China
by Lee Han-soo
2020-01-02 17:36
라인
FDA OKs Huons' generic of topic anesthetic injection
by Lee Han-soo
2020-01-02 14:30
Medytox launches liquid-type BTX 'Innotox 100 unit' in local market
by Lee Han-soo
2020-01-02 12:12
Korean biopharmaceuticals competitively move abroad to expand global presence
by Jeong Sae-im
2019-12-30 17:20
Migraine drug market heats up with Ubrelvy’s arrival
by Kim Yun-mi
2019-12-27 11:57
Local biopharmaceutical companies suffer from unsatisfactory P3 global trial results
by Jeong Sae-im
2019-12-27 07:06
라인
Dupixent to get coverage from January
by Kim Yun-mi
2019-12-24 15:40
‘Korea still slow to expand benefit for new drugs’
by Kim Yun-mi
2019-12-24 15:37
Shanghai Ocumension to market Huonland's HA eyedrop
by Lee Han-soo
2019-12-23 15:43
Alteogen's growth hormone deficiency treatment wins orphan drug status
by Lee Han-soo
2019-12-23 14:46
Daewoong partners with Aeon Biopharma to tap therapeutic BTX market
by Lee Han-soo
2019-12-23 11:23
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top